paroxetine has been researched along with Frigidity in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (46.15) | 18.2507 |
2000's | 15 (38.46) | 29.6817 |
2010's | 6 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abler, B; Graf, H; Metzger, CD; Walter, M | 1 |
Baldwin, D; Briley, M; Moreno, RA | 1 |
Goldstein, I; Kellner, CH; Korda, JB; Pfaus, JG | 1 |
Parish, SJ | 1 |
Chan, JS; de Jong, TR; Olivier, B; Oosting, RS; Snoeren, EM; Waldinger, MD | 1 |
DeRogatis, LR; Fabre, LF; Smith, LC | 1 |
Seftel, A | 1 |
Azuma, J; Hasegawa, R; Hiratsuka, K; Ishiwata, K; Kato, M; Kinoshita, T; Kurosawa, T; Kurose, K; Nishikawa, J; Nonen, S; Okugawa, G; Saito, Y; Wakeno, M | 1 |
Schruers, KR; Schutters, SI; van Megen, HJ; Van Veen, JF; Westenberg, HG | 1 |
Hadasová, E; Zourková, A | 1 |
Cohen, A; Dannon, PN; Grunhaus, L; Iancu, I; Kotler, M; Lowengrub, K | 1 |
Salerian, AJ | 1 |
Högberg, P; Landén, M; Thase, ME | 1 |
Brannan, SK; Delgado, PL; Detke, MJ; Mallinckrodt, CH; McNamara, RK; Tran, PV; Wang, F; Watkin, JG | 1 |
Kim, JJ; Kim, TS; Lee, C; Lee, CU; Lee, KU; Lee, SJ; Pae, CU; Paik, IH | 1 |
Baldwin, D; Bridgman, K; Buis, C | 1 |
Arakawa, R; Clayton, AH; Dunn, JA; Greist, JH | 1 |
Holman, JR; Kimmer, SL; Lo, V; Mercado, MG; Wanserski, G | 1 |
Clayton, AH; McGarvey, EL; Owens, JE | 1 |
Rothschild, AJ | 1 |
Althof, SE | 1 |
Isaksen, PM | 1 |
Segraves, RT | 1 |
MacHale, S; Phanjoo, AL | 1 |
Hengeveld, MW; Waldinger, MD; Zwinderman, AH | 1 |
Hsu, JH; Shen, WW | 1 |
Cirillo-Marucco, E; Corvasce, A; Ludovico, GM; Marano, A; Pagliarulo, A; Pagliarulo, G | 1 |
Balon, R | 1 |
Castronovo, V; Ferini-Strambi, L; Montorsi, F; Oldani, A; Rigatti, P; Smirne, S; Zucconi, M | 1 |
Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E | 1 |
Grimes, JB; Hines, A; Labbate, LA; Pollack, MH | 1 |
Amsterdam, JD; Deltito, JA; Dunner, DL; Fava, M; Salzman, C; Schwaller, M | 1 |
Anand, VS; Dewan, MJ | 1 |
Farah, A | 1 |
Ashton, AK | 1 |
Agren, H; Eriksson, E; Fahlén, T; Landén, M | 1 |
Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH | 1 |
Terao, T | 1 |
Erazo, N; Greil, W; Grohmann, R; Horvath, A; Sassim, N | 1 |
3 review(s) available for paroxetine and Frigidity
Article | Year |
---|---|
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
17 trial(s) available for paroxetine and Frigidity
Article | Year |
---|---|
SSRI-related modulation of sexual functioning is predicted by pre-treatment resting state functional connectivity in healthy men.
Topics: Adult; Brain; Cross-Over Studies; Depressive Disorder; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological | 2013 |
Resolution of sexual dysfunction during acute treatment of major depression with milnacipran.
Topics: Adult; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 2008 |
Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Delayed-Action Preparations; Depression; Double-Blind Method; Female; Humans; Libido; Paroxetine; Psychiatric Status Rating Scales; Psychological Tests; Pyrimidines; Sexual Dysfunctions, Psychological; Treatment Outcome | 2011 |
Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.
Topics: Adrenergic alpha-Antagonists; Adult; Anxiety Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome | 2011 |
Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects.
Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Depression; Female; Genotype; Humans; Male; Middle Aged; Paroxetine; Phenotype; Sexual Dysfunctions, Psychological; Treatment Outcome | 2003 |
Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
Topics: Adult; Agoraphobia; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Obesity; Panic Disorder; Paroxetine; Prevalence; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome; Weight Gain | 2004 |
Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
Topics: Buspirone; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Norway; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Sweden | 2005 |
Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.
Topics: Adult; Antidepressive Agents; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Incidence; Male; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Thiophenes; Treatment Outcome | 2005 |
Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Sexual Behavior; Sexual Dysfunctions, Psychological | 2006 |
Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology.
Topics: Adult; Data Collection; Double-Blind Method; Electronic Data Processing; Humans; Male; Office Visits; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Voice | 2007 |
Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire.
Topics: Adult; Depression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Self-Assessment; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Time Factors | 1995 |
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological | 1995 |
Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Double-Blind Method; Drug Administration Schedule; Ejaculation; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome | 1994 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
Topics: Adult; Ambulatory Care; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Gastrointestinal Diseases; Humans; Male; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Sexual Dysfunctions, Psychological; Treatment Outcome | 1998 |
Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Buspirone; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological | 1999 |
20 other study(ies) available for paroxetine and Frigidity
Article | Year |
---|---|
Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy.
Topics: Bipolar Disorder; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Paroxetine; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Substance Withdrawal Syndrome; Time Factors | 2009 |
Challenges in the identification and management of HSDD.
Topics: Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Recurrence; Risk Factors; Sexual Dysfunctions, Psychological; Treatment Outcome | 2009 |
A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Disease Models, Animal; Dopamine Agonists; Female; Male; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sexual Behavior, Animal; Sexual Dysfunctions, Psychological | 2011 |
Re: A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Dopamine Agonists; Female; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sexual Dysfunctions, Psychological | 2011 |
Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Asian People; Cohort Studies; Cyclopropanes; Depressive Disorder, Major; Female; Fluvoxamine; Genome-Wide Association Study; Genotype; GPI-Linked Proteins; Humans; Male; Middle Aged; Milnacipran; Neural Cell Adhesion Molecules; Paroxetine; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2012 |
Successful treatment of sexual dysfunction with dronabinol: a case report.
Topics: Adult; Benzodiazepines; Bipolar Disorder; Dronabinol; Female; Humans; Libido; Olanzapine; Paroxetine; Psychotropic Drugs; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Valproic Acid | 2004 |
Paroxetine-associated spontaneous sexual stimulation.
Topics: Depression; Female; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological | 2005 |
Clinical inquiries. What's the best drug treatment for premature ejaculation?
Topics: Anesthetics, Local; Antidepressive Agents; Clomipramine; Ejaculation; Fluoxetine; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Paroxetine; Phosphodiesterase Inhibitors; Prilocaine; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
[The effect of an antidepressive agent on premature ejaculation].
Topics: Adult; Antidepressive Agents; Ejaculation; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological | 1995 |
Treatment of drug-induced anorgasmia.
Topics: Female; Fluoxetine; Humans; Male; Orgasm; Paroxetine; Sexual Dysfunctions, Psychological; Yohimbine | 1994 |
SSRIs to treat sexual dysfunction.
Topics: Adult; Ejaculation; Humans; Male; Paroxetine; Sexual Dysfunctions, Psychological | 1994 |
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1995 |
Paroxetine in the treatment of premature ejaculation.
Topics: Adult; Antidepressive Agents, Second-Generation; Ejaculation; Humans; Male; Paroxetine; Recurrence; Sexual Dysfunctions, Psychological | 1996 |
Sleep-related painful erections: clinical and polysomnographic features.
Topics: Adrenergic beta-Antagonists; Adult; Amitriptyline; Humans; Lorazepam; Male; Middle Aged; Narcolepsy; Paroxetine; Penile Erection; Polysomnography; Propranolol; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Stages; Sleep, REM | 1996 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 1997 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
Sildenafil treatment of paroxetine-induced anorgasmia in a woman.
Topics: Anxiety Disorders; Female; Humans; Orgasm; Paroxetine; Phosphodiesterase Inhibitors; Piperazines; Purines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Treatment Outcome | 1999 |
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Female sexual dysfunction and antidepressant use.
Topics: Amantadine; Antidepressive Agents; Buspirone; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Meta-Analysis as Topic; Paroxetine; Personality Inventory; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome | 2001 |
Disinhibition of libido: an adverse effect of SSRI?
Topics: Adult; Adverse Drug Reaction Reporting Systems; Citalopram; Depression; Female; Humans; Libido; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Switzerland | 2001 |